BJP-2000-BECH-421-8

5 41 891 u 50300 dmi 2060 out 42 46 88 2 usa

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: .3 P 75^300 IP 20^80 Out 29 30 30 89 1 USA 16 F LUOX E T IN E v . P L A C E B O A N D T C A s I N S HO R T-T E R M T R E AT M E N T OF D E P R E S S I ON v. IN HOR 423 4 24 63 4 28, 96.5 U 50^150 TCA 24, 80.0 22, 75.9 P 75^150 IP 20 Out 30 29 59 2 2 21, 70.0 18, 54.5 P 50^225 DT 40^80 In/Out 30 33 63 5 3 23, 76.7 16, 57.1 U 100^200 DT 20^40 In/Out 30 28 58 3 4 14, 93.3 14, 93.3 P 50^175 CI 20^60 In 15 15 30 1 5 26, 68.4 25, 65.8 U 50^200 D 20^60 In/Out 38 38 76 1 6 16, 76.2 20, 95.2 U 100^250 AT 40^80 In/Out 21 21 42 14 7 28, 73.7 24, 64.9 U 75^300 AT 20^80 specified Not- 38 37 75 1 8 12, 85.7 11, 84.6 U 50^175 IP 20^60 Out 14 13 27 1 9 15, 100.0 15, 100.0 U 50^175 IP 20^60 In 15 15 30 1 10 Non-USA Non-USA Non-USA Non-USA Non-USA Non-USA Non-USA Non-USA AT, amitriptyline; IP, imipramine; D, doxepin; DT, dothiepin; CI, clomipramine; M, maprotiline. 30, 88.2 Fluoxetine Completers (n, %) Published (P)/unpublished (U) Dosage range (mg) M 40^80 Fluoxetine dosage range (mg) TCA Out 34 Fluoxetine TCA Status (in-patient/out-patient) 29 Total No. of patients 1 Non-USA Non-USA Description of the 14 non-USA trials (Europe and elsewhere) of fluoxetine v. tricyclic antidepressant (TCA) in major depression (DSM^III) No. of investigators Variables Table 1b T able 12, 80.0 9, 81.8 U 50^175 AT 20^60 In 15 11 26 1 11 Non-USA 10, 58.8 15, 100.0 U 50^175 IP 20 In/Out 17 15 32 1 12 Non-USA 12, 80.0 15, 100.0 P 50^175 IP 20 In/Out 15 15 30 1 13 Non-USA 19, 59.4 18, 60.0 P 50^200 CI 20 In 32 30 62 41 14 Non-USA B E CH E T AL F LUOX E T IN E v . P L A C E B O A N D T C A s I N S HO R T-T E R M T R E AT M E N T OF D E P R E S S I ON v. IN HOR received placebo and 686 had received TCAs (either amitriptyline, desipramine, doxepin, imipramine, or nortriptyline). A total of 96 patients were excluded, per our protocol, because they had been randomised to receive a fixed dose of 5 mg/ day of fluoxetine. Therefore, data for a total of 3447 patients were included in the meta-analyses (1914 in the fluoxetinetreated group, 847...
View Full Document

This note was uploaded on 01/16/2013 for the course BMS 620 taught by Professor Panavalil during the Summer '12 term at Barry Univesity.

Ask a homework question - tutors are online